Bardet-Biedl Syndrome Stem Cell Treatment in India

Bardet-Biedl Syndrome (BBS) Related Retinal Dystrophy

Bardet-Biedl Syndrome (BBS) is a rare inherited genetic disorder that affects multiple organs and systems of the body. One of the most serious and early manifestations of this condition is retinal dystrophy, which leads to progressive and irreversible vision loss. The retinal involvement in BBS is primarily due to degeneration of photoreceptor cells, especially rod and cone cells, resulting in gradual decline of visual function from childhood or adolescence.

BBS related retinal dystrophy typically begins with night blindness. Children with this condition often experience difficulty seeing in low-light environments, such as at dusk or in dimly lit rooms. Over time, peripheral vision gradually decreases, leading to tunnel vision. As the disease progresses further, cone photoreceptors also become affected, causing loss of central vision, reduced visual clarity, poor contrast sensitivity, and impaired colour perception. In advanced stages, many patients develop severe visual disability or legal blindness.

The retinal degeneration in Bardet-Biedl Syndrome is caused by mutations in a group of genes known as BBS genes, which play a crucial role in ciliary function. Cilia are microscopic structures present on many cells, including photoreceptors, and are essential for cellular signalling and transport. When ciliary function is impaired, photoreceptor cells cannot maintain their normal structure and metabolism, leading to progressive retinal degeneration.

In addition to visual impairment, BBS is associated with systemic features such as obesity, kidney abnormalities, hormonal imbalances, learning difficulties, polydactyly (extra fingers or toes), and hearing problems. Because BBS affects multiple organ systems, patients require long-term multidisciplinary medical care.

Diagnosis of BBS related retinal dystrophy involves a combination of ophthalmic evaluation and genetic testing. Retinal imaging techniques such as optical coherence tomography (OCT) help assess retinal structure and thickness. Electroretinography (ERG) typically shows reduced or absent retinal responses, confirming photoreceptor dysfunction. Visual field testing reveals progressive peripheral vision loss. Genetic analysis helps identify specific BBS gene mutations and confirms the diagnosis.

Currently, there is no definitive cure for Bardet-Biedl Syndrome or its associated retinal dystrophy. Conventional treatment focuses on visual rehabilitation, low-vision aids, orientation and mobility training, and educational support. Systemic management is essential for addressing kidney function, metabolic health, and endocrine abnormalities.

Stem cell therapy offers a regenerative and supportive approach aimed at preserving retinal function and slowing disease progression. At Eye Stem Cell Center, advanced regenerative protocols are designed to protect surviving photoreceptor cells, reduce oxidative stress, and improve the retinal microenvironment. Stem cells release neurotrophic factors, anti-inflammatory molecules, and growth signals that support retinal cell survival and neural function.

Although stem cell therapy cannot regenerate fully destroyed photoreceptors, it may help stabilize visual decline and improve functional vision in selected patients. The therapeutic goal is to preserve existing vision, enhance contrast sensitivity, improve light perception, and support daily visual activities.

Before initiating therapy, patients at Eye Stem Cell Center undergo comprehensive evaluation, including OCT, ERG, visual field analysis, systemic health screening, and neurological assessment where required. Treatment plans are fully personalized based on age, disease stage, genetic background, and overall medical condition.

Stem cell therapy for BBS related retinal dystrophy at Eye Stem Cell Center represents an advanced supportive option for patients facing progressive vision loss. By integrating regenerative medicine with specialized ophthalmic and systemic care, the center focuses on preserving remaining vision, improving functional independence, and enhancing long-term quality of life for individuals affected by this complex genetic disorder.

FAQs

Q1. What is Bardet-Biedl Syndrome?

A rare genetic disorder affecting vision, kidneys, metabolism, and physical development.

Q2. How does BBS affect eyesight?

It causes retinal dystrophy and progressive night blindness.

Q3. Is vision loss progressive in BBS?

Yes, vision typically worsens over time.

Q4. Can stem cell therapy help BBS?

Stem cells may help slow retinal degeneration and preserve visual function.

Q5. Is BBS inherited?

Yes, it follows an autosomal recessive inheritance pattern.